Kv3.3 could be a promising target given that reduced expression of Kv3.3 is observed at all stages of disease and that function-impairing mutations in Kv3.3 cause Spinocerebellar ataxia type 13 [55]. The gene discussed is KCNC3; the disease is spinocerebellar ataxia type 13.